Indrayani Biotech Ltd Stock Analysis

BSE: 526445 | NSE: | Floriculture | Small Cap

BSE Share Price Aug 19, 18:03
60.30 2.85 (4.96%)

DeciZen - Make an Informed Decision on Indrayani Biotech

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity

1. Quality

2. Valuation

Overvalued

3. Price Trend

Semi Strong

Indrayani Biotech Price Chart

P/E Ratio (SA) :
42.07
Market Cap :
196.6 Cr.
52-wk low :
13.3
52-wk high :
63.8
Bole Toh?

1. Is Indrayani Biotech Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Indrayani Biotech Ltd is a below average quality company.

2. Is Indrayani Biotech Ltd undervalued or overvalued?

The key valuation ratios of Indrayani Biotech Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Indrayani Biotech Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Indrayani Biotech Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Indrayani Biotech:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Indrayani Biotech Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
ROCE % -2.4%-1.2%-2%-2.9%-3.7%-5.9%6,826.7%732.2%186.4%-37.7%-
Value Creation Index -1.2-1.1-1.1-1.2-1.3NANANANANA-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 000000000.52159
YoY Gr. Rt. %-NANANANANANANANA4,102%-
Adj EPS -0.2-0.1-0.2-0.3-0.4-0.3-0.3-0.2-0.6-2.31.4
YoY Gr. Rt. %-NANANANANANANANANA-
BVPS (₹) 9.49.49.28.98.6-1.3-1.7-1.8-2.45.87.4
Adj Net Profit -0.10-0.1-0.1-0.1-0.1-0.1-0.1-0.2-85
Cash Flow from Ops. 00.1-0.1-0.1-0.1-0.1-0.1-0.20.10.5-
Debt/CF from Ops. 01.9-2.2-2.9-3-4.6-5.1-3.18.729.8-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANA4102%
Adj EPS NANANANA
BVPS -5.2-7.400
Share Price 28.6% 52.2% 129.3% 299.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
Return on Equity % -2.4-1.2-2.1-3.1-4.1-7.8238.627.1-83.920.7
Op. Profit Mgn % 00000000-30.8-22.210.8
Net Profit Mgn % 00000000-41-38.17.9
Debt to Equity 0000.10.1-1-1-1-0.80.8-
Working Cap Days 0000000049900
Cash Conv. Cycle 00000000-101220

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 20.70%

Sales growth is good in last 4 quarters at 118.56%

Sales growth has been subdued in last 3 years 0.00%

Net Profit has been subdued in last 3 years 0.00%

Latest Financials - Indrayani Biotech Ltd.

Standalone Consolidated
TTM EPS (₹) 1.4 1.6
TTM Sales (₹ Cr.) 59.3 73
BVPS (₹.) 7.4 7.6
Reserves (₹ Cr.) -9 -8
P/BV 7.74 7.64
PE 42.07 36.90
From the Market
52 Week Low / High (₹) 13.26 / 63.80
All Time Low / High (₹) 0.50 / 63.80
Market Cap (₹ Cr.) 197
Equity (₹ Cr.) 34.2
Face Value (₹) 10
Industry PE 53.5

Management X-Ray of Indrayani Biotech :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Login/Register to view analysis.

Key Ratios of Indrayani Biotech

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

News

About Indrayani Biotech Ltd

The company was incorporated on March 9, 1992 and it was converted into a public limited company on March 13, 1992. It is into floriculture and is engaged in the cultivation of cut flowers, plantlets and seeds.

Indrayani Biotech produces cut flowers, strawberries, tissue culture plantlets and hybrid vegetable seeds. The company has also started marketing and distribution and extensive field demonstrations of hybrid vegetable seeds manufactured by HOECHST India. Technical agreements have been signed with Floral Max, Malaysia for rose cultivation and with B. L. McKenzie and Associates, New Zealand for tissue culture. The planting material for strawberries has been acquired from the US. Indrayani Biotech has signed a test agreement with the technology transfer offer of the University of California to obtain certified planting material from nurseries in California.

Indrayani Biotech started exporting flowers to Holland and Dubai in 1994-1995. Restricted water supply and changes in ecology resulted in a shortfall in achieving its goals. In 1995-1996, the company incurred losses due to insufficient water supply, labor problems and sub-standard infrastructure. To overcome the above problems, the company is considering shifting its green houses to alternate locations.

The company has installed five Greenhouses and plantation in these greenhouses is complete.  A pilot tissue culture laboratory is also completed and the protocol to be used in manufacture of tissue culture plantlets is being perfected. 

The company’s registered office and factory are located at Pune, India.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now